Accurate bulk quantitation of droplet digital PCR. Read more about Accurate bulk quantitation of droplet digital PCR.
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking. Read more about Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking.
Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients. Read more about Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients.
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models. Read more about Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models.
Global Absence and Targeting of Protective Immune States in Severe COVID-19. Read more about Global Absence and Targeting of Protective Immune States in Severe COVID-19.
Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses. Read more about Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses.
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies. Read more about Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies.
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells. Read more about SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation. Read more about An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike. Read more about Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike.
